Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)GlobeNewsWire • 03/22/24
Here is What to Know Beyond Why Novartis AG (NVS) is a Trending StockZacks Investment Research • 03/14/24
Novartis (NVS) Advances While Market Declines: Some Information for InvestorsZacks Investment Research • 03/11/24
Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General MeetingGlobeNewsWire • 03/05/24
Novartis presents new data on safety and efficacy of Zolgensma, including maintained and improved motor milestones in older and heavier children with SMAGlobeNewsWire • 03/04/24
This grouping of stocks has actually kept up with the Magnificent Seven, and with a lot less riskMarket Watch • 02/12/24
Novartis to acquire German Biotech MorphoSys for $2.9B, Expanding Cancer Drug PipelineInvestopedia • 02/06/24